Skip to main content
User account menu
Log In
Contact Us
Search
Search
Enter the terms you wish to search for.
Main navigation
Community
Chapters
College of Fellows
Program Leadership
Program Leaders
Divisions
CRS Diversified Products: Delivery Beyond Pharma
Equity, Diversity & Inclusion
Focus Groups
Bioengineering
Gene Delivery and Gene Editing (GDGE)
Immuno Delivery (ID)
Nanomedicine and Nanoscale Delivery (NND)
Ocular Delivery (OcD)
Oral Delivery (OrD)
Skin and Mucosal Delivery (SMD)
Industry
Industry Advisory Group
Industry Foresight Council
Opportunities for Partnering
Young Scientist Committee
Meet the YSC Team
YSC Workshops
Women in Science
Events
2024 Annual Meeting and Expo
2024 CRS YSC Intersociety Webinar
Harnessing Innovation in Drug Delivery for Women's Health-Virtual Symposium
Past Annual Meeting Locations
Past Symposia
Upcoming Events
Publications
Meet the Team
News
Drug Delivery and Translational Research
Journal of Controlled Release
Books
CRS Inside Track
Annual Meeting Archives
Membership
Join or Renew
Corporate Membership
Member Benefits and Fees
CRS Member Directory
Regional Discounts
Get Involved
Sponsored Membership Program
StreamCRS
Member News
Resources
Awards
2024 Awards
CRS Exceptional Leadership Award
Distinguished Service Award
Drug Delivery and Translational Research Journal Outstanding Paper Award
Founders Award
Jorge Heller Journal of Controlled Release Outstanding Paper Award
Member of the Year Award
PhD Thesis Award
Samyang Award
Transdermal Delivery Kydonieus Foundation Award
Young Investigator Award
Women in Science Award
Rising Women in Science Award
Sponsor
CRS Industry Sponsors
About CRS
Governance & Leadership
Board of Directors 2023-2024
CRS Bylaws
Strategic Plan
History
CRS Past Presidents
Careers
Job Center
CRS Foundation
Foundation Contributions
Foundation Awards Granted
Invitation to Industry
CRS Headquarters Team
Compiled by Steven Giannos, Independent Consultant
Companies in the News
Authors:
Compiled by Steven Giannos, Independent Consultant
March
Ironwood Pharmaceuticals Initiates Phase IIb Clinical Trial of IW-3718 in Refractory Gastroesophageal Reflux Disease
Business Wire: March 23, 2016 – CAMBRIDGE, MA, U.S.A. –…
